Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cipla Ltd. Regulatory Filings 2021

Oct 26, 2021

59275_rns_2021-10-26_4291df57-15e4-4f66-9e42-b4f50ee46cfe.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

26[th] October, 2021

(1) BSE Ltd. (2) National Stock Exchange of India Ltd. Listing Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5[th] floor, Dalal Street Plot no. C/1, G Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA

(3) SOCIETE DE LA BOURSE DE LUXEMBERG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Grant of stock options and employee stock appreciation rights

Dear Sir / Madam,

This is to inform you that the Company has made the following grants in terms of the Employee Stock Option Scheme 2013-A (“ESOS 2013-A”) and the Cipla Employee Stock Appreciation Rights Scheme 2021 (“ESAR 2021”) under SEBI (Share Based Employee Benefits) Regulations, 2014:

No. of Vesting period Exercise
S. N. Scheme Type of Option options /
ESARs
period
granted
1. ESOS 2013-A Stock options* 9752
9752
2years from thegrant date
1year from thegrant date
5 years from
2. ESAR 2021 Employee Stock Appreciation
Rights(ESARs)**
31970
37041
3yearsgraded vesting
1year from thegrant date
vesting date

* Exercise price Rs. 2/- per stock option

** Exercise price Rs. 2/- per equity share

Kindly take the above information on record.

Thanking you,

Yours faithfully, For Cipla Limited

RAJENDR Digitally signed by RAJENDRA A KUMAR KUMAR CHOPRA Date: 2021.10.26 CHOPRA 18:56:38 +05'30'

Rajendra Chopra

Company Secretary

Prepared by: Pratiksha Mangaonkar